Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome

Psycho-Oncology

Volumn 17, Issue 8, 2008, Pages 783-789

  Peterson, Susan K ^a   Pentz, Rebecca D ^b   Marani, Salma K ^a   Ward, Patricia A ^c   Blanco, Amie M ^d   LaRue, Denise ^a   Vogel, Kristen ^a   Solomon, Tamara ^a   Strong, Louise C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Li Fraumeni; Oncology; p53; Psychosocial

Indexed keywords

PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CLINICAL DECISION MAKING; CONTROLLED STUDY; COPING BEHAVIOR; DISTRESS SYNDROME; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATIENT ATTITUDE; PERSONAL EXPERIENCE; QUALITY OF LIFE; RISK ASSESSMENT; SELF CONCEPT; SEX DIFFERENCE; SOCIAL PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CONFLICT (PSYCHOLOGY); DECISION MAKING; FEMALE; FOLLOW-UP STUDIES; GENES, P53; GENETIC COUNSELING; HUMANS; LI-FRAUMENI SYNDROME; MIDDLE AGED; NEOPLASMS; POINT MUTATION; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SELF EFFICACY; YOUNG ADULT;

EID: 51649111024     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1352     Document Type: Article

References (38)

1. Malkin D, Li FP, Strong LC. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250(4985):1233-1238.
2. Frebourg T, Barbier N, Yan YX et al. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 1995; 56:608-615.
3. Varley JM, McGown G, Thorncroft M et al. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 1997;57: 3245-3252.
4. Bougeard G, Limacher JM, Martin C et al. Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families. J Med Genet 2001;38:253-257.
5. Hwang SJ, Lozano G, Amos CL et al. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 2003; 72:975-983.
6. Hisada MGJ, Fung CY, Fraumeni Jr JF, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst Monogr 1998;90(8): 606-611.
7. Chompret A, Brugieres L, Ronsin M et al. P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 2000;82(12):1932-1937.
8. Saslow D, Boetes C, Burke W et aL. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. C A Cancer J Clin 2007;57: 75-89.
9. Schneider KA, Li F. Li-Fraumeni syndrome. Gene Rev 2004.
10. Varley JM, Evans DGR, Birch JM. Li-Fraumeni syndrome: a molecular and clinical review. Br J Cancer 1997;76(1):1-14.
11. Gritz ER, Vernon SW, Peterson SK et al. Distress in the cancer patient and its association with genetic testing and counseling for hereditary non-polyposis colon cancer. Cancer Res Ther Control 1999;8:35-49.
12. Lerman C, Schwartz MD, Lin TH et al. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 1997;65(3):414-420.
13. Lerman C, Croyle RT, Tercyak KP et al. Genetic testing: psychological aspects and implications. J Consult Clin Psychol 2002;70(3):784-797.
14. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology 2005;14(12):1060-1074.
15. Dorval M, Patenaude AF, Schneider KA et al. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs. J Clin Oncol 2000;18(10):2135-3142.
16. Gritz ER, Peterson SK, Vernon SW et al. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23(9):1902-1910.
17. Wellisch DK, Gritz ER, Schain W et al. Psychological functioning of daughters of breast cancer patients (Part I: daughters and comparison subjects). Psychosomatics 1991;32:324-336.
18. Wellisch DK, Gritz ER, Schain W et al. Psychological functioning of daughters of breast cancer patients (Part II: characterizing the distressed daughter of the breast cancer patient). Psychosomatics 1992;33(2):171-179.
19. Esplen MJ, Hunter J. Grief in women with a family history of breast cancer. Prim Psychiatry 2002;9(5): 57-64.
20. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ et al. Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Ann Oncol 2006;17(7):1090-1095.
21. Barrera M, D'Agostino NM, Gibson J et al. Predictors and mediators of psychological adjustment in mothers of children newly diagnosed with cancer. Psycho-Oncology 2004;13:630-641.
22. Oppenheim D, Brugieres L, Chompret A et al. The psychological burden inflicted by multiple cancers in Li-Fraumeni families: five case studies. J Genet Couns 2001;10(2):169-183.
23. Patenaude AF, Schneider KA, Kieffer SA et al. Acceptance of invitations for p53 and BRCA1 predisposition testing: factors influencing potential utilization of cancer genetic testing. Psycho-Oncology 1996;5:241-250.
24. Strong LC, Stine M, Norsted TL. Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst 1987; 79(6):1213-1220.
25. Lustbader ED, Williams WR, Bondy ML et al. Segregation analysis of cancer in families of childhood soft-tissue sarcoma patients. Am J Hum Genet 1992; 51(2):344-356.
26. Peterson SK, Pentz RD, Blanco AM et al. Evaluation of a decision aid for families considering p53 genetic counseling and testing. Genet Med 2006;8(4):226-233.
27. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979;41:209-218.
28. Ferrans CE, Ferrell BR. Development of a quality of life index for patients with cancer. Oncol Nurs Forum 1990;17(3):15-19.
29. Ferrans C, Powers M. Psychometric assessment of the Quality of Life Index. Res Nurs Sci 1992;15:29-38.
30. Sarason IG, Levine HM, Basham RB et al. Assessing social support: the social support questionnaire. J Pers Soc Psychol 1983; 1(1):127-139.
31. Bowen DJ, Patenaude AF, Vernon SW. Psychosocial issues in cancer genetics: from the laboratory to the public. Cancer Epidemiol Biomarkers Prev 1999; 8:326-328.
32. Lerman C, Trock B, Rimer BK et al. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991; 114:657-661.
33. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995;15(1):25-30.
34. Codori AM, Petersen GM, Miglioretti DL et al. Attitudes toward colon cancer gene testing: factors predicting test uptake. Cancer Epidemiol Biomarkers Prev 1999;8(4 Pt 2):345-351.
35. Schwartz MD, Hughes C, Roth J et al. Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol Biomarkers Prev 2000;9:381-385.
36. Peterson SK. The role of the family in genetic testing: theoretical perspectives, current knowledge, and future directions. Health Educat Behav 2005;32(5):627-639.
37. Erblich BJ, Bovbjerg DH, HB V. Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 2000; 22(1):53-59.
38. Henderson BJ, Tyndel S, Brain K et al. Factors associated with breast cancer-specific distress in younger women participating in a family history mammography screening programme. Psycho-Oncology 2008;17(1): 74-82.